$GERN Cashflow Statement | Understand Stock

$GERN

$1.15 +$0.00 (0.0%) Close

$GERN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Accretion and amortization on investments, net
Amortization of debt issuance costs/debt discount
Net gain on exchange and sales of equity investment
Payment on royalty agreement
Non-cash interest expense on liabilities for sales of future royalities
Non-cash interest expense on liabilities for sales of future royalties
Loss of extinguishment of debt
Stock-based compensation for services by non-employees
Stock-based compensation for employees and directors
Amortization of right-of-use assets
Increase in allowance for doubtful accounts

Changes in assets and liabilities:
Inventory
Accounts receivable, net
Interest and other receivables
Prepaid expenses and other assets
Deposit and other assets
Accounts payable
Accrued compensation and benefits
Royalty financing obligation
Accrued liabilities
Operating lease liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Purchases of marketable securities
Proceeds from sales of equity investment
Proceeds from maturities and sales of marketable securities
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from issuances of common stock from equity plans
Proceeds from issuance of common stock and warrants in public offering, net of paid issuance costs
Proceeds from issuances of common stock from at market offerings, net of paid issuance costs
Proceeds from exercise of warrants
Proceeds from sale of future royalties
Proceeds from debt financing, net of paid debt issuance costs and debt discounts
Repayment of debt
Net cash provided by financing activities

Net effect of exchange rates on cash, cash equivalents and restricted cash
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of the period
Cash, cash equivalents and restricted cash at the end of the period

Comments